Nutex Health reports Q4 results; authorizes stock repurchase program of up to $25M

* Nutex Health press release [https://seekingalpha.com/pr/20426886-nutex-health-reports-2025-financial-results-and-announces-second-stock-repurchase-program] (NUTX [https://seekingalpha.com/symbol/NUTX]): Q4 Revenue of $151.7M (-41.1% Y/Y) misses by $107.12M.
* Adjusted EBITDA attributable to Nutex Health of $16.6 million, as compared to Adjusted EBITDA attributable to Nutex Health of $86.7 million for the three months ended December 31, 2024, a decrease of 80.8%.
* Total visits at the Hospital Division were 48,205 for the three months ended December 31, 2025, as compared to 45,444 for the same period in 2024, an increase of 2,761 or 6.1%. Visits at mature hospitals decreased by 0.3% in the three months ended December 31, 2025 as compared to the same period in 2024.
* Net cash from operating activities of $70.4 million for the three months ended December 31, 2025, as compared to $0.1 million for the same period in 2024.
* The board of directors has authorized a second stock repurchase program of up to $25.0 million of the company's common stock over the next six months.

MORE ON NUTEX HEALTH

* Nutex Health: The $387 Million Receivables Problem And The Legislative Silver Bullet [https://seekingalpha.com/article/4875205-nutex-health-the-387-million-receivables-problem-and-the-legislative-silver-bullet]
* Nutex: Stellar Growth But Sustainability Doubts Linger [https://seekingalpha.com/article/4856944-nutex-stellar-growth-but-sustainability-doubts-linger]
* Seeking Alpha’s Quant Rating on Nutex Health [https://seekingalpha.com/symbol/NUTX/ratings/quant-ratings]
* Historical earnings data for Nutex Health [https://seekingalpha.com/symbol/NUTX/earnings]
* Financial information for Nutex Health [https://seekingalpha.com/symbol/NUTX/income-statement]